TRLS.L Stock Analysis
TR
Uncovered
Trellus Health PLC is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
Trellus Health Plc engages in the provision of digital chronic condition management solutions for employers and health plans. The company is headquartered in Penarth, South Glamorgan and currently employs 23 full-time employees. The company went IPO on 2021-05-28. The firm is focused on the intersection of chronic physical conditions and mental health. The firm is focused on inflammatory bowel disease (IBD), which includes the chronic incurable conditions of Crohn’s Disease and ulcerative colitis. The TrellusElevate platform is the Company's connected health platform that incorporates the Gaining Resilience Through Transitions (GRITT) methodology and learnings on resilience from clinical research and practice. Through its TrellusElevate connected care platform and companion App, the Company addresses both clinical and behavioral health together. The Company’s wholly owned subsidiary is Trellus Health Inc.